Large pharmaceutical companies say allowing Medicare to negotiate lower drug prices will stifle innovation in drug development. Read a new op-ed in Harvard Business Review to find out why that’s not so.
Senior Research Assistant, Department of Health Policy and Management, Milken Institute School of Public Health, George Washington University
Rachel Gunsalus, M.P.H. candidate, is a senior research assistant in the Department of Health Policy and Management at the George Washington University’s Milken Institute School of Public Health.